Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
265,957,447
-
Total 13F shares
-
52,992,751
-
Share change
-
+962,004
-
Total reported value
-
$1,158,352,799
-
Put/Call ratio
-
41%
-
Price per share
-
$21.87
-
Number of holders
-
153
-
Value change
-
+$26,029,052
-
Number of buys
-
74
-
Number of sells
-
75
Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) as of Q2 2023
As of 30 Jun 2023 Outset Medical, Inc. - Common Stock, par value $0.001 per share (the "Shares") (OM) had 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,992,751 shares of stock of the company.
Largest 10 holders included FMR LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BlackRock Inc., T. Rowe Price Investment Management, Inc., Bellevue Group AG, Champlain Investment Partners, LLC, MILLENNIUM MANAGEMENT LLC, BRAIDWELL LP, and AMERIPRISE FINANCIAL INC.
This table shows 153 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.